NZ759901A - Solid oral pharmaceutical compositions of dabigatran etexilate - Google Patents
Solid oral pharmaceutical compositions of dabigatran etexilateInfo
- Publication number
- NZ759901A NZ759901A NZ759901A NZ75990118A NZ759901A NZ 759901 A NZ759901 A NZ 759901A NZ 759901 A NZ759901 A NZ 759901A NZ 75990118 A NZ75990118 A NZ 75990118A NZ 759901 A NZ759901 A NZ 759901A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical compositions
- solid oral
- oral pharmaceutical
- dabigatran etexilate
- etexilate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/06848A TR201706848A2 (tr) | 2017-05-10 | 2017-05-10 | Dabigatran eteksi̇lat i̇çeren kati oral farmasöti̇k kompozi̇syonlar |
TR2018/06309A TR201806309A2 (tr) | 2017-05-10 | 2018-05-04 | Dabigatran eteksi̇lat i̇çeren kati oral farmasöti̇k kompozi̇syonlar |
PCT/TR2018/050221 WO2019004980A2 (en) | 2017-05-10 | 2018-05-10 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN DEXILATE |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ759901A true NZ759901A (en) | 2021-12-24 |
Family
ID=64559741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ759901A NZ759901A (en) | 2017-05-10 | 2018-05-10 | Solid oral pharmaceutical compositions of dabigatran etexilate |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP3621599A2 (es) |
AU (1) | AU2018293361B2 (es) |
BR (1) | BR112019023781A2 (es) |
CO (1) | CO2019013649A2 (es) |
EA (1) | EA201992644A1 (es) |
NZ (1) | NZ759901A (es) |
TR (2) | TR201706848A2 (es) |
WO (1) | WO2019004979A2 (es) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE121699A1 (es) | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | Heterociclos biciclicos disustituidos como inhibidores de la trombina |
DE10337697A1 (de) | 2003-08-16 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze |
SI2588090T1 (sl) * | 2010-07-01 | 2017-06-30 | Krka, D.D., Novo Mesto | Trdne peroralne farmacevtske oblike, ki obsegajo dabigatran eteksilat in njegove farmacevtsko sprejemljive soli |
EP3858337A3 (en) * | 2012-02-21 | 2021-09-29 | Towa Pharmaceutical Europe, S.L. | Oral pharmaceutical compositions of dabigatran etexilate |
EP2740471B1 (en) | 2012-12-07 | 2015-05-27 | Hexal AG | Oral pharmaceutical composition comprising dabigatran etexilate |
CN104784147B (zh) * | 2014-01-20 | 2018-01-23 | 成都苑东生物制药股份有限公司 | 一种甲磺酸达比加群酯胶囊药物组合物及其制备方法 |
IN2014MU01042A (es) | 2014-03-26 | 2015-10-02 | Cadila Healthcare Ltd | |
WO2015155297A1 (en) * | 2014-04-11 | 2015-10-15 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Pharmaceutical combinations of dabigatran and h2-receptor antagonists |
CN104095830A (zh) * | 2014-05-22 | 2014-10-15 | 万特制药(海南)有限公司 | 一种甲磺酸盐达比加群酯胶囊的制备方法 |
CN105560206A (zh) * | 2014-10-13 | 2016-05-11 | 重庆圣华曦药业股份有限公司 | 一种达比加群酯胶囊的制备 |
WO2016142821A2 (en) * | 2015-03-09 | 2016-09-15 | Alphamed Formulations Pvt. Ltd | Compositions containing a thrombin inhibitor |
IN2015CH01145A (es) * | 2015-03-09 | 2016-09-16 |
-
2017
- 2017-05-10 TR TR2017/06848A patent/TR201706848A2/tr unknown
-
2018
- 2018-05-04 TR TR2018/06309A patent/TR201806309A2/tr unknown
- 2018-05-10 EP EP18811674.3A patent/EP3621599A2/en not_active Withdrawn
- 2018-05-10 EP EP18811675.0A patent/EP3634388A2/en not_active Withdrawn
- 2018-05-10 AU AU2018293361A patent/AU2018293361B2/en not_active Ceased
- 2018-05-10 WO PCT/TR2018/050220 patent/WO2019004979A2/en unknown
- 2018-05-10 EA EA201992644A patent/EA201992644A1/ru unknown
- 2018-05-10 NZ NZ759901A patent/NZ759901A/en not_active IP Right Cessation
- 2018-05-10 BR BR112019023781-0A patent/BR112019023781A2/pt not_active Application Discontinuation
-
2019
- 2019-12-03 CO CONC2019/0013649A patent/CO2019013649A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3621599A2 (en) | 2020-03-18 |
WO2019004979A3 (en) | 2019-04-11 |
AU2018293361A1 (en) | 2020-01-02 |
BR112019023781A2 (pt) | 2020-06-02 |
EP3634388A2 (en) | 2020-04-15 |
AU2018293361B2 (en) | 2021-09-16 |
CO2019013649A2 (es) | 2020-05-15 |
TR201706848A2 (tr) | 2018-11-21 |
TR201806309A2 (tr) | 2018-11-21 |
EA201992644A1 (ru) | 2020-04-07 |
WO2019004979A2 (en) | 2019-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY197700A (en) | Compounds useful for inhibiting cdk7 | |
MD4800C1 (ro) | Compuşi de aminopirimidinil ca inhibitori de JAK | |
MX2017008518A (es) | Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih). | |
IL270812A (en) | Solid compositions for oral drug administration | |
PH12019501639A1 (en) | Jaki selective inhibitors | |
PH12017500029A1 (en) | 4,5-dihydroisoxazole derivatives as nampt inhibitors | |
IN2013CH05441A (es) | ||
EA201691670A1 (ru) | Тетразолонзамещенные дигидропиридиноновые ингибиторы mgat2 | |
EA202092829A1 (ru) | Композиции тофацитиниба с контролируемым высвобождением | |
IN2014MN02245A (es) | ||
MX2020011756A (es) | Compuesto farmaceutico, sales del mismo, formulaciones del mismo y metodos para hacer y usar el mismo. | |
WO2016142821A3 (en) | Compositions containing a thrombin inhibitor | |
WO2019004980A3 (en) | SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN DEXILATE | |
IN2013MU00665A (es) | ||
TR201714882A2 (tr) | Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari | |
NZ759901A (en) | Solid oral pharmaceutical compositions of dabigatran etexilate | |
WO2020032885A3 (en) | Capsule-in-capsule compositions of dabigatran etexilate | |
IN2014MU00859A (es) | ||
TR201722323A2 (tr) | Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari | |
TR201722186A2 (tr) | Dabi̇gatranin farmasöti̇k kompozi̇syonlari | |
IN2013MU03421A (es) | ||
IN2013MU03422A (es) | ||
MX2015015290A (es) | Compuestos furanona como inhibidores de quinasa. | |
EA201991288A1 (ru) | Фармацевтические композиции на основе дабигатрана | |
MX2018010652A (es) | Composiciones farmaceuticas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
LAPS | Patent lapsed |